| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Profit before tax | -1.0 | -1.7 |
| Net income | -1.0 | -1.7 |
| EPS (diluted, $ a share) | $-0.10 | $-0.20 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
Source
Read the filing ↗
10-Q filed with the SEC, OTC: APTN. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Adaptin Bio, Inc.: key numbers
- Shares outstanding
- 9.26MLatest SEC cover page
- Sector
- Life Sciences
- Industry
- Biological Products, (No Diagnostic Substances)SIC 2836
Today's reference numbers, updated daily. Not a valuation or a recommendation.